Swiss pharmaceutical company Novartis reported better-than-expected sales in Q4, with net sales rising 16% to $13.2 billion, exceeding analyst estimates. However, full-year sales fell short of guidance at $50.32 billion, while core operating income for 2024 increased to $19.5 billion. CEO Vas Narasimhan highlighted the company’s strong financial performance and growth outlook for 2025, focusing on advancing their development pipeline with over 30 assets for long-term growth.
Full Article
Edward Coristine, Key Player on Elon Musk’s DOGE Team, Resigns
Edward Coristine, a 19-year-old operative for the Department of Government Efficiency known as "Big Balls," resigned amid criticism of his inexperience and controversial background. Hired by Elon Musk's team to reduce federal bureaucracy, he oversaw various agency projects, including budget cuts at the State Department and immigration visa sales, before his email was deactivated following his resignation. Explain It To Me Like I'm 5: Edward Coristine, a young government worker known as "Big Balls," quit...
Read more